Stifel Financial
VIVO

Stifel Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Stifel Financial’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,790
Closed -$524K – 3467
2022
Q4 		$524K Sell
15,790
-9,440
-37% -$304K ﹤0.01% 2440
2022
Q3 		$796K Sell
25,230
-26,835
-52% -$869K ﹤0.01% 2128
2022
Q2 		$1.58M Sell
52,065
-256
-0.5% -$6.92K ﹤0.01% 1658
2022
Q1 		$1.36M Buy
52,321
+3,941
+8% +$93.7K ﹤0.01% 1902
2021
Q4 		$987K Sell
48,380
-14,850
-23% -$285K ﹤0.01% 2142
2021
Q3 		$1.22M Sell
63,230
-11,166
-15% -$223K ﹤0.01% 1934
2021
Q2 		$1.65M Buy
74,396
+33,594
+82% +$713K ﹤0.01% 1741
2021
Q1 		$1.07M Buy
40,802
+8,822
+28% +$210K ﹤0.01% 1944
2020
Q4 		$598K Buy
31,980
+3,920
+14% +$73.2K ﹤0.01% 2210
2020
Q3 		$476K Buy
+28,060
New +$545K ﹤0.01% 2123
2017
Q1 		– Sell
-27,690
Closed -$489K – 2623
2016
Q4 		$489K Buy
27,690
+12,039
+77% +$211K ﹤0.01% 1786
2016
Q3 		$302K Buy
15,651
+576
+4% +$11.3K ﹤0.01% 1987
2016
Q2 		$294K Buy
15,075
+440
+3% +$8.63K ﹤0.01% 2053
2016
Q1 		$302K Buy
+14,635
New +$288K ﹤0.01% 1817

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Stifel Financial's VIVO Position: Q1 2023 in Review

Stifel Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 15,790 shares — an estimated $524K sold.

Stifel Financial first reported a position in VIVO in Q1 2016 and held it in 14 quarters. The position peaked at $1.65M in Q2 2021. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Stifel Financial reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Stifel Financial sold 15,790 Meridian Bioscience Inc shares in Q1 2023, an estimated $524K.
  • Stifel Financial first reported a position in Meridian Bioscience Inc in Q1 2016 and held it in 14 quarters.
  • Stifel Financial's Meridian Bioscience Inc position peaked at $1.65M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Stifel Financial's 13F filing for Q1 2023, filed 12 May 2023.